2.1. Study Design and Participants
In this single-centre, randomized-controlled, double-masked, three-period, three-intervention, cross-over study, participants consumed two different doses of the investigational product, or a control product, for 7 consecutive days. The study protocol was approved by the Institutional Review Board of Orange County Research Center, USA, and Temasek Polytechnic, Glycemic Index Research Unit, Singapore, and the study was carried out in compliance with the Harmonized Tripartite Guideline for Good Clinical Practice from the International Conference on Harmonisation [